PPT-MTN-028 Study Overview Phase 1 Pharmacokinetic Trial of Two Intravaginal Rings (IVRs)
Author : liane-varnes | Published Date : 2018-12-06
Vicriviroc MK4176 and MK2048 MTN028 Study Specific Training MTN028 BackgroundRationale Intravaginal Rings IVRs may offer an ideal method of drug delivery for
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "MTN-028 Study Overview Phase 1 Pharmacok..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
MTN-028 Study Overview Phase 1 Pharmacokinetic Trial of Two Intravaginal Rings (IVRs): Transcript
Vicriviroc MK4176 and MK2048 MTN028 Study Specific Training MTN028 BackgroundRationale Intravaginal Rings IVRs may offer an ideal method of drug delivery for HIV prevention Discreet. Module 3: Overview of Prevention Research. www.icad-cisd.com. UNDERSTANDING THE RESEARCH PROCESS. Clinical Trials Process. Preclinical. Phase I. Phase II. Phase IIB. “Test of Concept”. Phase III. oncology. Shu-Fang Hsu Schmitz. University of Bern, Bern, Switzerland . Phase I trials . First in human. Ever first in human, or for a specific indication, or for a specific combination . treatment, or for a specific dosing schedule. David N. Assis, MD. Assistant Professor of Medicine. Yale University. I have no disclosures relevant to this presentation.. Clinical Trials in PSC. PSC is a rare disease . 32,000 patients in the US. PSC has no proven and approved treatment. Plain Language Summary Roadshow. (Educational Material). Agenda. Vision . Overview . of . Plain Language Summary . Plain Language Summary Program. Vision. <Insert Company Vision>. Overview of Lay Patient Summary. Part 2. Resident and Fellows Lecture Series. A. pril 12, 2016. Elizabeth Garrett-Mayer, . PhD. Hollings Cancer . Center. . Current State of Phase II. Lots of changes in the past several years. Phase I . This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. (emphasis on fruits and vegetables and their components). Steven K. Clinton, M.D., Ph.D.. The Ohio State University. 2. Introduction. 3. What is a Clinical Trial:. Essential Characteristics. “a . prospective. Collecting data. 2. Data . Statistics is a way of thinking—thinking about ways to . gather. and analyze data.. Trust data. 3. 3. Resource of Data. Experiment/ clinical trial. Survey. http://www.nhs.uk/Conditions/Clinical-trials/Pages/Healthresearch.aspx. Outline. Review of a phase I trial. What is a phase II trial?. Phase II trial process. Standard trial designs. Innovative trial designs. Phase II trial examples. Guess that trial. Phase II thalidomide study. Mary Kay Koenig, MD. Associate Vice Chair for Clinical Research. Co-Director for the Tuberous Sclerosis Center of Excellence. Department of Pediatrics. Division of Child & Adolescent Neurology. University of Texas McGovern Medical School. Walter K. Kraft. Fall 2018. Sage words from an . olde. . tyme. drug developer. When . the molecule is born, its fate is determined. It's up to . us to . find out what the truth is, but in the end we can't change . A case study of ‘best practices’ in community engagement. Ms . Maureen . Njue . Dr Patricia . Njuguna. KEMRI . Wellcome. Trust Research Programme, Kenya.. . Outline . KEMRI-Wellcome Trust, Kilifi . B. rain . I. njury . T. reatment Trial: A Multicenter Phase II Adaptive Clinical Trial. . Gaylan. . Rockswold. , MD, PhD, Principal Investigator. Thomas Bergman, MD, Site Principal Investigator. Overview. A Feasibility Study. SciSIP. PI Conference, September 2012. Ernst R. Berndt. Iain M. Cockburn. MIT, Boston University, and . National Bureau of Economic Research. What?. Analysis of trends in costs of doing clinical trials.
Download Document
Here is the link to download the presentation.
"MTN-028 Study Overview Phase 1 Pharmacokinetic Trial of Two Intravaginal Rings (IVRs)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents